Health Care·Biotechnology·$5.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.20 | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| N/A |
Tone: Defensive
Management expressed caution regarding current market conditions. They emphasized a commitment to their long-term strategy despite not providing specific guidance.
Management did not provide specific insights into revenue performance.
The focus remains on long-term strategic goals despite current challenges.
Celcuity Inc reported a loss per share of $0.20, but did not disclose revenue figures. The stock fell by 3% following the earnings announcement, likely due to the lack of detailed financial metrics and guidance, which may have left investors uncertain about the company's near-term performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
TYSON FOODS INC Class A
Nov 13, 2017